(Q48164564)

9 February 2018

title

Antiepileptic drugs and cerebral glucose metabolism (English)

1 reference

9 February 2018

author name string

Theodore WH

series ordinal

1

1 reference

9 February 2018

publication date

1 January 1988

1 reference

9 February 2018

published in

Epilepsia

1 reference

9 February 2018

volume

29 Suppl 2

1 reference

9 February 2018

page(s)

S48-55

1 reference

9 February 2018

Cerebral protective, metabolic, and vascular effects of phenytoin.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Effects of sodium valproate and acetazolamide on cerebral respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Effects of hypnotic drugs on memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Localizing 3H-GABA in Nerve Terminals of Rat Cerebral Cortex by Electron Microscopic Autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Patterns of metabolic activity in the treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

A comparison of the effects of pentobarbital and diphenylhydantoin on the GABA sensitivity and excitability of adult sensory ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

The inhibition of terminal oxidation by porphyrinogenic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Dose dependent reduction of glucose utilization by pentobarbital in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Positron emission tomography in schizophrenic patients with and without neuroleptic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Alzheimer's disease: focal cortical changes shown by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Brain metabolism in man; unanesthetized and in pentothal narcosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Cerebral glucose utilization following striatal lesions: the effects of the GABA agonist, muscimol, and the dopaminergic agonist, apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Cerebral blood flow in epileptic children during the interseizure period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Local cerebral glucose utilization in non-rapid eye movement sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Pseudodegenerative Disease Due to Diphenylhydantoin Intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Memory impairment in epileptic patients: selective effects of phenobarbital concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

The distribution of alterations in energy metabolism in the rat brain produced by apomorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Distribution of effects of haloperidol on energy metabolism in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Drug interactions at the GABA receptor-ionophore complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Use of 2-deoxy-D[1-11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Normal human sleep: regional cerebral hemodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Inhibition of amino acid transmitter release from rat brain slices by phenytoin and related anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Relation between physiological function and energy metabolism in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

The influence of anticonvulsant drugs on formyl tetrahydrofolic acid stimulation of rat brain respiration in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Rates of cerebral glucose utilization in rats anaesthetized with phenobarbitone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Diazepam and (--)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Effect of phenytoin on human cerebral glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Barbiturates reduce human cerebral glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Cerebral glucose metabolism in the Lennox-Gastaut syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Site of anticonvulsant action on sodium channels: autoradiographic and electrophysiological studies in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1988.TB05797.X

Cerebral blood flow and metabolism in schizophrenia; the effects of barbiturate semi-narcosis, insulin coma and electroshock

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1176/AJP.104.12.765

10.1111/J.1528-1157.1988.TB05797.X

21 August 2022

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018